Jay-Z-backed MarcyPen Capital Partners is in advanced discussions to acquire LVMH's 50% stake in Fenty Beauty, potentially becoming co-owner alongside Rihanna. The deal, valued between US$1 billion and US$2 billion, signals a major shift in ownership structure for the high-profile beauty brand, which generated approximately S$450 million in net sales in 2024. For overseas distributors and clinic buyers, this acquisition could reshape supply-chain dynamics and brand partnerships in the medical aesthetics and beauty sector.
Deal structure and valuation
MarcyPen Capital Partners, which manages around S$1.1 billion in assets, is the leading candidate to purchase LVMH's half of Fenty Beauty. LVMH has reportedly retained investment bank Evercore to explore options for its stake. The beauty brand's valuation ranges between US$1 billion and US$2 billion, based on 2024 net sales of roughly S$450 million. MarcyPen has been exploring multiple financing options, including discussions with outside investors, according to sources close to the matter.
About MarcyPen Capital Partners
MarcyPen was founded in 2018 by Jay-Z, Roc Nation co-founder Jay Brown, and venture capitalist Larry Marcus. The firm manages about S$1.1 billion in assets and has a track record of backing forward-thinking brands, including Rihanna's Savage x Fenty, Partake Foods, and web3 startup Spatial Labs. Pendulum Holdings, established in 2019 by Robbie Robinson and D'Rita Robinson, has also been active in private equity, with investments in Greenwood Bank and Adwoa Beauty.
What buyers should watch
For medical aesthetics distributors and clinic buyers, this potential ownership change could influence Fenty Beauty's supply-chain relationships, product development priorities, and distribution strategies. The involvement of Jay-Z and MarcyPen may signal increased focus on inclusive beauty and innovative product lines, potentially opening new sourcing opportunities for OEM and packaging partners. Buyers should monitor how the acquisition affects brand positioning and channel access in the medical aesthetics space.
Regulatory and channel signals
The acquisition discussions come amid broader consolidation trends in the beauty and personal care industry. LVMH's decision to divest its stake may reflect strategic portfolio adjustments, while MarcyPen's entry could bring fresh capital and entrepreneurial vision. Overseas importers and distributors should watch for any changes in Fenty Beauty's distribution agreements, pricing structures, or product categories that could impact their supply-chain planning.
Source: Read the original report | Published: June 16, 2026